Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2010

Open Access 01-12-2010 | Research

Comparison of venous plasma glycemia and capillary glycemia for the screening of type 2 diabetes mellitus in the Japanese-Brazilian community of Mombuca (Guatapará-SP)

Authors: Maria Cristina Foss-Freitas, Regina CG de Andrade, Roberta C Figueiredo, Ana Emília Pace, Edson Z Martinez, Amaury L Dal Fabro, Laércio J Franco, Milton C Foss

Published in: Diabetology & Metabolic Syndrome | Issue 1/2010

Login to get access

Abstract

Background

To identify the most appropriate cut-off points of fasting glycemia for the screening of diabetes mellitus type 2 (DM2) with the comparison of the properties of capillary glycemia (CG) and venous blood plasma glycemia (PG) in a population of Japanese origin from the community of Mombuca, Guatapará - SP, Brazil.

Methods

This was a population-based descriptive cross-sectional study conducted on a sample of 131 individuals of both genders aged 20 years or more (66.8% of the target population). CG was measured with a glucometer in a blood sample obtained from the fingertip and PG was determined by an enzymatic method (hexokinase) in venous blood plasma, after a 10-14 hour fast in both cases. Data were analyzed by the receiver operating characteristic (ROC) curve in order to identify the best cut-off point for fasting glycemia (CG and PG) for the diagnosis of DM, using the 2-hour plasma glycemia > 200 mg/dl as gold - standard.

Results

The ROC curve revealed that the best cut-off point for the screening of DM was 110 mg/dl for CG and 105 mg/dl for PG, values that would optimize the relation between individuals with positive and false-positive results. The area under the ROC curve was 0.814 for CG (p < 0.01) and 0.836 for PG (p < 0.01).

Conclusions

The cut-off points of 105 mg/dl(5.8 mmol/l) for PG and of 110 mg/dl(6.1 mmol/l) for CG appear to be the most appropriate for the screening of DM2 in the population under study, with emphasis on the fact that the value recommended for CG is 5 mg/dl higher than that for PG, in contrast to WHO recommendations.
Appendix
Available only for authorised users
Literature
1.
go back to reference King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998, 21: 1414-1431. 10.2337/diacare.21.9.1414.CrossRefPubMed King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998, 21: 1414-1431. 10.2337/diacare.21.9.1414.CrossRefPubMed
2.
go back to reference Wild S, Roglicroglic G, Green A, Sicree R, King H: Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglicroglic G, Green A, Sicree R, King H: Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
3.
go back to reference Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica: Diabetes Mellitus/Cadernos de Atenção Básica-no.16, Normas e Manuais Técnicos, Brasília-DF. 2006, 64- Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica: Diabetes Mellitus/Cadernos de Atenção Básica-no.16, Normas e Manuais Técnicos, Brasília-DF. 2006, 64-
4.
go back to reference American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003, 26: 917-932. 10.2337/diacare.26.3.917.CrossRef American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003, 26: 917-932. 10.2337/diacare.26.3.917.CrossRef
5.
go back to reference Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris LL, Shuman WP, Stolov WC, Whal PW: Prevalence of diabetes mellitus and impaired glucose tolerance among second generation Japanese American men. Diabetes. 1987, 36: 721-729. 10.2337/diabetes.36.6.721.CrossRefPubMed Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris LL, Shuman WP, Stolov WC, Whal PW: Prevalence of diabetes mellitus and impaired glucose tolerance among second generation Japanese American men. Diabetes. 1987, 36: 721-729. 10.2337/diabetes.36.6.721.CrossRefPubMed
6.
go back to reference Hara H, Egusa G, Yamakido M, Kawate R: The high prevalence of diabetes mellitus and hyperinsulinemia among the Japanese-Americans living in Hawaii and Los Angeles. Diabetes Res Clin Pract. 1994, 24 (Suppl): S37-S42. 10.1016/0168-8227(94)90225-9.CrossRefPubMed Hara H, Egusa G, Yamakido M, Kawate R: The high prevalence of diabetes mellitus and hyperinsulinemia among the Japanese-Americans living in Hawaii and Los Angeles. Diabetes Res Clin Pract. 1994, 24 (Suppl): S37-S42. 10.1016/0168-8227(94)90225-9.CrossRefPubMed
7.
go back to reference Franco LJ, Gimeno SGA, Ferreira SRG, Iunes M: Incremento na Mortalidade associada à presença de Diabetes Mellitus em nipo-brasileiros. Revista de Saúde Pública. 1998, 32: 118-124.CrossRefPubMed Franco LJ, Gimeno SGA, Ferreira SRG, Iunes M: Incremento na Mortalidade associada à presença de Diabetes Mellitus em nipo-brasileiros. Revista de Saúde Pública. 1998, 32: 118-124.CrossRefPubMed
8.
go back to reference Gimeno SGA, Ferreira SRG, Franco LJ, Hirai AT, Matsumura RS, Moisés RS: Prevalence and 7-year incidence of Type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia. 2002, 45: 1635-1638. 10.1007/s00125-002-0963-x.CrossRefPubMed Gimeno SGA, Ferreira SRG, Franco LJ, Hirai AT, Matsumura RS, Moisés RS: Prevalence and 7-year incidence of Type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia. 2002, 45: 1635-1638. 10.1007/s00125-002-0963-x.CrossRefPubMed
9.
go back to reference Malerbi DA, Franco LJ: Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in urban Brazilian population aged 30-69 years. Diabetes Care. 1992, 15: 1509-1516. 10.2337/diacare.15.11.1509.CrossRefPubMed Malerbi DA, Franco LJ: Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in urban Brazilian population aged 30-69 years. Diabetes Care. 1992, 15: 1509-1516. 10.2337/diacare.15.11.1509.CrossRefPubMed
10.
go back to reference Grupo de Estudos de Diabetes na Comunidade Nipo-Brasileira (JBDSG): Diabetes Mellitus e Doenças Associadas em Nipo-Brasileiros. 2004, São Paulo: Gree Forest do Brasil Editora Grupo de Estudos de Diabetes na Comunidade Nipo-Brasileira (JBDSG): Diabetes Mellitus e Doenças Associadas em Nipo-Brasileiros. 2004, São Paulo: Gree Forest do Brasil Editora
11.
go back to reference UK Prospective Diabetes Study(UKPDS)Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998, 352: 837-853. 10.1016/S0140-6736(98)07019-6.CrossRef UK Prospective Diabetes Study(UKPDS)Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998, 352: 837-853. 10.1016/S0140-6736(98)07019-6.CrossRef
12.
go back to reference Georg AE, Duncan BB, Toscano CM, Schmidt MI, Mengue S, Duarte C, Polaczyk CA: Economic analysis of a screening program for diabetes mellitus in Brazil. Rev Saúde Pública. 2005, 39: 452-460. 10.1590/S0034-89102005000300017.CrossRefPubMed Georg AE, Duncan BB, Toscano CM, Schmidt MI, Mengue S, Duarte C, Polaczyk CA: Economic analysis of a screening program for diabetes mellitus in Brazil. Rev Saúde Pública. 2005, 39: 452-460. 10.1590/S0034-89102005000300017.CrossRefPubMed
13.
go back to reference American Diabetes Association: Standards of Medical Care in Diabetes. Diabetes Care. 2008, 31 (s1): S5-S11. American Diabetes Association: Standards of Medical Care in Diabetes. Diabetes Care. 2008, 31 (s1): S5-S11.
14.
go back to reference American Diabetes Association: Screening for Type 2 Diabetes. Diabetes Care. 2003, 26 (s1): S21-S24. American Diabetes Association: Screening for Type 2 Diabetes. Diabetes Care. 2003, 26 (s1): S21-S24.
15.
go back to reference Oliveira JEP, Milech A: Diabetes Mellitus- Clínica, Diagnóstico e Tratamento Multidisciplinar. 2004, São Paulo: Editora Atheneu Oliveira JEP, Milech A: Diabetes Mellitus- Clínica, Diagnóstico e Tratamento Multidisciplinar. 2004, São Paulo: Editora Atheneu
16.
go back to reference Worldworld Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999, Genebra WHO Worldworld Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999, Genebra WHO
17.
go back to reference Pagano M, Gauvreau K: Princípios de Bioestatística. 2006, São Paulo: Thomson Learning Pagano M, Gauvreau K: Princípios de Bioestatística. 2006, São Paulo: Thomson Learning
18.
go back to reference Delong ER, Delong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a non parametric approach. Biometrics. 1988, 44: 837-845. 10.2307/2531595.CrossRefPubMed Delong ER, Delong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a non parametric approach. Biometrics. 1988, 44: 837-845. 10.2307/2531595.CrossRefPubMed
19.
go back to reference Harris MI, Eastman RC: Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000, 16: 230-236. 10.1002/1520-7560(2000)9999:9999<::AID-DMRR122>3.0.CO;2-W.CrossRefPubMed Harris MI, Eastman RC: Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000, 16: 230-236. 10.1002/1520-7560(2000)9999:9999<::AID-DMRR122>3.0.CO;2-W.CrossRefPubMed
20.
go back to reference Engelgau MM, Narayan KMV, Herman WH: Screening for type 2 diabetes. Diabetes Care. 2000, 23: 1563-1580. 10.2337/diacare.23.10.1563.CrossRefPubMed Engelgau MM, Narayan KMV, Herman WH: Screening for type 2 diabetes. Diabetes Care. 2000, 23: 1563-1580. 10.2337/diacare.23.10.1563.CrossRefPubMed
21.
go back to reference Colagiuri S, Sandbaek A, Carstensen B, Christensen J, Glumer C, Lauritzen T, Borch-Jonhsen K: Comparability of venous and capillary glucose measurements in blood. Diabetic Medicine. 2003, 20: 953-956. 10.1046/j.1464-5491.2003.01048.x.CrossRefPubMed Colagiuri S, Sandbaek A, Carstensen B, Christensen J, Glumer C, Lauritzen T, Borch-Jonhsen K: Comparability of venous and capillary glucose measurements in blood. Diabetic Medicine. 2003, 20: 953-956. 10.1046/j.1464-5491.2003.01048.x.CrossRefPubMed
22.
go back to reference Kruijshoop M, Feskens EJM, Blaak EE, Bruin TWA: Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population. Clinica Chimica Acta. 2004, 341: 33-40. 10.1016/j.cccn.2003.10.033.CrossRef Kruijshoop M, Feskens EJM, Blaak EE, Bruin TWA: Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population. Clinica Chimica Acta. 2004, 341: 33-40. 10.1016/j.cccn.2003.10.033.CrossRef
23.
go back to reference Kuwa K, Nakayama T, Hoshino T, Tominaga M: Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clinica Chimica Acta. 2001, 307: 187-192. 10.1016/S0009-8981(01)00426-0.CrossRef Kuwa K, Nakayama T, Hoshino T, Tominaga M: Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clinica Chimica Acta. 2001, 307: 187-192. 10.1016/S0009-8981(01)00426-0.CrossRef
24.
go back to reference Stahl M, Brandslund I, Jorgensen LG, Hyltoft Petersen P, Borch-Johnsen K, de Fine Olivarius N: Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus?. Scand J Clin Lab Invest. 2002, 62: 159-166. 10.1080/003655102753611799.CrossRefPubMed Stahl M, Brandslund I, Jorgensen LG, Hyltoft Petersen P, Borch-Johnsen K, de Fine Olivarius N: Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus?. Scand J Clin Lab Invest. 2002, 62: 159-166. 10.1080/003655102753611799.CrossRefPubMed
25.
go back to reference Stahl M, Brandslund I: Measurement of glucose content in plasma from capillary blood in diagnosis of diabetes mellitus. Scand J Clin Lab Invest. 2003, 63: 431-440. 10.1080/00365510310002590.CrossRefPubMed Stahl M, Brandslund I: Measurement of glucose content in plasma from capillary blood in diagnosis of diabetes mellitus. Scand J Clin Lab Invest. 2003, 63: 431-440. 10.1080/00365510310002590.CrossRefPubMed
26.
go back to reference Arduino F: Sintomas, Diagnóstico, Prognóstico e Mortalidade do Diabetes. Diabetes Mellitus. Edited by: Arduino F. 1980, Rio de Janeiro: Editora Guanabara Koogan, 78-94. 3 Arduino F: Sintomas, Diagnóstico, Prognóstico e Mortalidade do Diabetes. Diabetes Mellitus. Edited by: Arduino F. 1980, Rio de Janeiro: Editora Guanabara Koogan, 78-94. 3
Metadata
Title
Comparison of venous plasma glycemia and capillary glycemia for the screening of type 2 diabetes mellitus in the Japanese-Brazilian community of Mombuca (Guatapará-SP)
Authors
Maria Cristina Foss-Freitas
Regina CG de Andrade
Roberta C Figueiredo
Ana Emília Pace
Edson Z Martinez
Amaury L Dal Fabro
Laércio J Franco
Milton C Foss
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2010
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-2-6

Other articles of this Issue 1/2010

Diabetology & Metabolic Syndrome 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.